SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 41 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $76 | +1.3% | 76,000 | 0.0% | 0.00% | – |
| Q4 2022 | $75 | -99.9% | 76,000 | 0.0% | 0.00% | – |
| Q3 2022 | $74,000 | -64.6% | 76,000 | -64.8% | 0.00% | – |
| Q2 2022 | $209,000 | +6866.7% | 216,000 | +7100.0% | 0.00% | – |
| Q2 2021 | $3,000 | -99.5% | 3,000 | -99.5% | 0.00% | – |
| Q4 2020 | $627,000 | -36.0% | 655,000 | -45.9% | 0.00% | -100.0% |
| Q1 2020 | $979,000 | +30.0% | 1,210,000 | +46.3% | 0.00% | – |
| Q4 2019 | $753,000 | +37.2% | 827,000 | +40.2% | 0.00% | – |
| Q3 2019 | $549,000 | +200.0% | 590,000 | +205.7% | 0.00% | – |
| Q2 2019 | $183,000 | – | 193,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 37,347,000 | $36,345,000 | 4.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 51,663,000 | $49,804,000 | 2.44% |
| Wellesley Asset Management | 19,638 | $19,107,000 | 2.29% |
| Radcliffe Capital Management, L.P. | 58,877,000 | $56,759,000 | 2.26% |
| DeepCurrents Investment Group LLC | 29,151,000 | $28,254,000 | 0.97% |
| Penn Mutual Asset Management, LLC | 675,000 | $651,000 | 0.74% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,212,000 | $6,056,000 | 0.71% |
| Sonora Investment Management, LLC | 5,775,000 | $5,568,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,802,000 | $22,095,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 23,405,000 | $22,701,000 | 0.19% |